Caplin Point Laboratories’ injectables facility completes INVIMA audit successfully
This is also an important milestone in our product strategy for our expansion into the larger Latin American market
This is also an important milestone in our product strategy for our expansion into the larger Latin American market
The investment in land is Rs. 19.85 crore
Caplin Point Laboratories has reported total income of Rs. 564.41 crore during the period ended September 30, 2025
Caplin Point Laboratories has reported total income of Rs. 533.36 crores during the period ended June 30, 2025
Hikal Limited announces the completion of the US Food and Drug Administration (USFDA) inspection at its Jigani unit, Bengaluru
EPS climbs to Rs 9.25 for the quarter
Acetaminophen Injection is indicated for the management of mild to moderate pain in adult and pediatric patients 2 years and older
Nicardipine Hydrochloride in 0.9% Sodium Chloride Injection is indicated for the short-term treatment of hypertension when oral therapy is not feasible or desirable
Milrinone is indicated for the short-term intravenous treatment of patients with acute decompensated heart failure
Haloperidol Decanoate Injection indicated for the treatment of patients with schizophrenia who require prolonged parenteral antipsychotic therapy
Subscribe To Our Newsletter & Stay Updated